Google
ONCO — ONCONETIX INC (Healthcare >> Biotechnology)
ONCO FAQ
What is ONCO's P/E ratio?
ONCONETIX INC (ONCO) currently trades at a P/E ratio of 0.20.
What is ONCO's ROE?
ONCONETIX INC reports a Return on Equity (ROE) of -82.59%.
What is ONCO's dividend yield?
ONCONETIX INC offers a dividend yield of 0.00%.
What is ONCO's Deepscope Quality Score?
Deepscope rates ONCO's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ONCO?
Deepscope's AI Timing Score for ONCO is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ONCO belong to?
ONCONETIX INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.09
Price
0.04
(3.81%)
Day Change
|
|
|---|
ONCO, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 81 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.09 |
| PBV / Sector |
0.10 / 4.79
GREAT
|
| Earning Per Share | -9.36 |
| PE / Sector |
0.20 / 18.05
GREAT
|
| PEG or PE/Growth / Sector |
-0.01 / 0.62
|
| Average 1M Daily Value |
1.70 M
GREAT
|
| Average 1W Daily Value |
0.36 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
47% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-12 09:42:56 |
| Symbol | ONCO |
| Name | ONCONETIX INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 1.15 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1.13 / 9,010.81 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 201 East Fifth Street, Cincinnati, OH, United States, 45202
Phone: 513 620 4101
Website: https://www.onconetix.com
Sector: Healthcare >> Biotechnology
Description: Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
